FOXP3 and diabetes mellitus: We provide additional insight, as shown by the loss of FOXP3+ cells observed in the lidocaine-treated group in Figure 6C. Peng et al. demonstrated that TGF-beta regulated the in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells, contributing to protection against diabetes [31].